Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivek P Chavda

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Drug Discovery Today|September 8, 2022
Successes and failures of immunotherapy for gastric cancerJianzheng Wang, Shuiping Tu, Vivek P Chavda, et al.
Drug Discovery Today|July 31, 2021
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 managementVivek P Chavda, Lalitkumar K Vora, Anjali K Pandya, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Peptide-Drug Conjugates: A New Hope for Cancer ManagementVivek P Chavda, Hetvi K Solanki, Majid Davidson, et al.
Immunotherapy|June 9, 2022
Therapeutics to tackle Omicron outbreakVivek P Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M Yallapu, et al.
Vaccines|October 27, 2022
Epigenetics in Tuberculosis: Immunomodulation of Host Immune ResponseAvinash Khadela, Vivek P Chavda, Humzah Postwala, et al.
Nanotheranostics|May 8, 2023
Current status of Cancer Nanotheranostics: Emerging strategies for cancer managementVivek P Chavda, Avinash Khadela, Yasha Shah, et al.
Cancers|January 21, 2023
Configuring Therapeutic Aspects of Immune Checkpoints in Lung CancerAvinash Khadela, Vivek P Chavda, Humzah Postwala, et al.
Vaccines|December 23, 2022
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future PandemicsVivek P Chavda, Shailvi Soni, Lalitkumar K Vora, et al.
Cancers|January 8, 2023
Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast CancerAvinash Khadela, Vivek P Chavda, Shruti Soni, et al.
Expert Review of Vaccines|August 5, 2022
Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 managementVivek P Chavda, Aayushi B Patel, Lalitkumar K Vora, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Drug Discovery Today|September 8, 2022
Successes and failures of immunotherapy for gastric cancerJianzheng Wang, Shuiping Tu, Vivek P Chavda, et al.
Drug Discovery Today|July 31, 2021
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 managementVivek P Chavda, Lalitkumar K Vora, Anjali K Pandya, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Peptide-Drug Conjugates: A New Hope for Cancer ManagementVivek P Chavda, Hetvi K Solanki, Majid Davidson, et al.
Immunotherapy|June 9, 2022
Therapeutics to tackle Omicron outbreakVivek P Chavda, Eswara Naga Hanuma Kumar Ghali, Murali M Yallapu, et al.
Vaccines|October 27, 2022
Epigenetics in Tuberculosis: Immunomodulation of Host Immune ResponseAvinash Khadela, Vivek P Chavda, Humzah Postwala, et al.
Nanotheranostics|May 8, 2023
Current status of Cancer Nanotheranostics: Emerging strategies for cancer managementVivek P Chavda, Avinash Khadela, Yasha Shah, et al.
Cancers|January 21, 2023
Configuring Therapeutic Aspects of Immune Checkpoints in Lung CancerAvinash Khadela, Vivek P Chavda, Humzah Postwala, et al.
Vaccines|December 23, 2022
mRNA-Based Vaccines and Therapeutics for COVID-19 and Future PandemicsVivek P Chavda, Shailvi Soni, Lalitkumar K Vora, et al.
Cancers|January 8, 2023
Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast CancerAvinash Khadela, Vivek P Chavda, Shruti Soni, et al.
Expert Review of Vaccines|August 5, 2022
Dendritic cell-based vaccine: the state-of-the-art vaccine platform for COVID-19 managementVivek P Chavda, Aayushi B Patel, Lalitkumar K Vora, et al.
Pageof 12